After five years Cornerstone Robotics adheres to the corporate mission of ” making surgery safe and broadening life ” , insists on independent innovation, and is committ to building a safe and efficient surgical robot platform. Connosten has establish libya email list 100000 contact leads three R&D centers around the world, fully mastering core technologies such as mechanical architecture, electrical architecture, software architecture, complex algorithms, and visual imaging, and independently building the underlying technical platform for surgical robots; and has a mass production factory of over 10,000 square meters in the Greater Bay Area, successfully realizing the ” independent research and development, independent manufacturing ” of surgical robots .
2024 is the first year of commercialization of Connosten
The company’s independently develop Sentire® laparoscopic surgical robot was officially approv for marketing by the China National Mical Products Administration (NMPA) on September 29 , 2024.
Relying on the highquality performance and as we know in life cost advantages of independent research and development and independent manufacturing, Connosten has cooperat with top mical centers in mainland China, Hong Kong and Europe, and successfully complet clinical cases in several important specialties as plann. This has laid a solid foundation for the company’s highquality development in the future to expand into the international market and serve global mical care.
On the other hand, Connosten is also actively exploring more application scenarios
An clinical cooperation opportunities around the world to accelerate the popularization of technology and services. By cooperating with mical and trust review ucational institutions, the company has made solid progress in implementing application and skills training. At the same time, clinical feback and the team’s research and development of innovative technologies form a virtuous circle, allowing robots to be integrat with artificial intelligence to complete more precise and complex surgeries, allowing technological development to promote the popularization of smart mical care and better serve society and the public After five years.